KRM Ayurveda P/B Ratio

Current P/B Ratio
4.46
High Valuation
Very High - Significant premium, high growth expectations or speculative

KRM Ayurveda (KRMAYURVED) P/B ratio is 4.46 (High), book value per share ₹54.76 vs Healthcare average P/B of -0.26 — Very High - Significant premium, high growth expectations or speculative. Review KRMAYURVED PE ratio trends to evaluate earnings-based valuation against sector peers.

Current Valuation Metrics

P/B Ratio 4.46
Current Price
Book Value/Share ₹54.76
Exchange None

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹115 Cr
Share Capital ₹21 Cr
Reserves & Surplus ₹93 Cr
Outstanding Shares 21,000,000
Book Value per Share ₹54.76

Valuation Signal

Signal Overvalued

Sector Context

Sector Average -0.26
Sector Median 0.56
Sector Rank #11 of 50
Sector Percentile 22.0%

KRMAYURVED P/B Ratio — Valuation Insights & Book Value Analysis

KRM Ayurveda price-to-book ratio interpretation, valuation status and historical context — current P/B 4.46 (High). View KRMAYURVED 52-week chart for the annual high/low range and current price position.

  • Stock appears overvalued with PB of 4.46, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Trading at premium to sector average PB of -0.26

KRMAYURVED vs Healthcare Peers — P/B Ratio Comparison

KRM Ayurveda P/B 4.46 vs Healthcare average -0.26, median 0.56 — range -12.44–1.1.

Sector Average
-0.26
Sector Median
0.56
Lowest P/B
-12.44
Highest P/B
1.1
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -12.44 ₹15 Low
Span Divergent SDL -6.32 ₹19 Low
Parmax Pharma PARMAX -5.61 ₹39 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.1 ₹69 Low
Krebs Biochemicals & Ind… KREBSBIO -0.7 ₹112 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹44 Low